Zobrazeno 1 - 1
of 1
pro vyhledávání: '"ID Signal Oncohaematology Grp"'
Autor:
Sanchez-Ramon, Silvia, Bermudez, Arancha, Ignacio Gonzalez-Granado, Luis, Rodriguez-Gallego, Carlos, Sastre, Ana, Soler-Palacin, Pere, Alonso, Laura, Allende, Luis, Alsina, Laia, Maria Bielsa, Ana, Calleja-Antolin, Sara, Camara, Carmen, Carbone, Javier, Carreras, Carmen, De Andres Martin, Ana, Deya, Angela, Diaz de Heredia, Cristina, Dieli-Crimi, Romina, Luis Diez, Jose, Dominguez-Pinilla, Nerea, Fernandez-Pereira, Luis, Ma Garcia, Jose, Gil-Herrera, Juana, Gutierrez, Antonio, Jarque, Isidro, Juan, Manel, Lendinez, Francisco, Llobet, Pilar, Lopez, Monica, Lopez de la Guia, Ana, Lopez-Hoyos, Marcos, Martin-Nalda, Andrea, Martinez, Monica, Melero, Josefa, Mendez-Echevarria, Ana, Moral, Pedro, Neth, Olaf, Nunez, Maria, Ocejo-Vinyals, Gonzalo, Ochoa-Grullon, Juliana, Olbrich, Peter, Ona, Raquel, Perez-Encinas, Manuel, Pons, Jaime, Rodriguez, Carmen, Sanchez, Berta, Luis Santos-Perez, Juan, Elena Seoane, Ma, Vlagea, Alexandru, ID Signal Oncohaematology Grp
Publikováno v:
Frontiers in Immunology
Scientia
Frontiers in Immunology, Vol 10 (2019)
Scientia
Frontiers in Immunology, Vol 10 (2019)
Background: Immunodeficiencies (ID), in particular primary immunodeficiencies (PID), are often associated with haematological manifestations, such as peripheral cytopenias or lymphoproliferative syndromes. Early diagnosis and management have signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf94051a54bb8f0f558f2ff342061532
https://doi.org/10.3389/fimmu.2019.00586
https://doi.org/10.3389/fimmu.2019.00586
